DailyIQ
Last updatedjust now

CME·CME Group Inc.

$275.99
+4.86 (+1.79%)
Market Closed (Overnight)$276.01+0.02 (+0.01%)
High
$277.49
Open
$271.89
Market Cap
97.50B
52W High
$329.16
Low
$267.00
P. Close
$275.99
P/E
22.74
52W Low
$218.31
Fwd P/E
21.35
DailyIQ Est.
$285.30
Inst. Ownership
41.4%
Short Interest
1.59%
Days to Cover
2.8
Technical Score (1D)
59
BUY
News Sentiment
54
MIXED
CME Group’s launch of S&P UBS USD Liquid Leveraged Loan Index futures just 2.7 hours ago expands the exchange’s product lineup into leveraged‑loan exposure, offering a liquid, index‑based vehicle that could attract institutional and retail traders seeking fixed‑income alternatives. The new contract’s introduction signals CME’s intent to capture a share of the growing leveraged‑loan market, which has been underrepresented in futures. At the same time, the exchange reported record 24/7 trading volumes in gold and silver futures, underscoring robust retail participation in precious‑metal markets and suggesting that CME’s high‑volume strategy is resonating with traders. The leadership promotions at CME’s top tier reinforce a strategic focus on high‑volume markets, implying that the firm will continue to prioritize products that drive liquidity and trading fees. For the next 1–10 trading days, the launch of the leveraged‑loan futures could lift CME’s earnings and market share, while the sustained retail interest in metals may keep those contracts highly liquid. Watch for early trading activity of the new leveraged‑loan futures to gauge market acceptance and for any subsequent fee or margin adjustments that could affect profitability. Additionally, monitor CME’s quarterly earnings releases for any commentary on the impact of these new products on revenue streams. Finally, keep an eye on broader fixed‑income market conditions, as shifts in interest rates or credit spreads could influence demand for leveraged‑loan exposure and, by extension, CME’s new offering.
Earnings Summary
CME Group Inc. is a global marketplace that facilitates trading of futures and options across interest rates, equity indexes, foreign exchange, commodities, and energy, while also providing clearinghouse services and risk mitigation solutions. Operating within the financial services sector and the financial data & stock exchanges industry, CME Group supports a broad clientele of professional traders and institutions. Over the last four quarters, CME’s earnings per share have shown a steady upward trend, with Q4 2025 EPS of $2.77 versus Q4 2024 EPS of $2.52, and Q1 2026 EPS of $3.36 versus Q1 2025 EPS of $2.80, reflecting a consistent acceleration in profitability. Revenue has also grown, with Q4 2025 revenue of $1.65 billion slightly below the $1.67 billion estimate, while Q1 2026 revenue of $1.88 billion exceeded the $1.78 billion forecast, indicating a pattern of beating revenue estimates in three of the last four quarters. Historically, CME has maintained a YoY revenue growth rate of approximately 5–6% over the past three years, with EPS growth consistently outpacing revenue growth; the company has beaten analyst EPS estimates in 6 of the last 10 quarters, though revenue has occasionally matched or slightly missed estimates. Recent news focuses on the Federal Reserve’s anticipated rate hike, which is expected to increase demand for CME’s FedWatch analytics and boost trading volumes in interest‑rate futures, thereby potentially lifting revenue; oil price surges and insider selling by CEO Terrence Duffy also add market dynamics that could influence short‑term trading activity. Investors should watch for confirmation of the Fed rate hike, changes in the FedWatch gauge, and any shifts in CME’s trading volumes or revenue guidance in the next earnings release, as these will be key indicators of the firm’s short‑term performance trajectory.

EPS

EstBeatMiss
$2.52$2.76$2.99$3.23$3.47Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$2.94 - -
Q2'26$2.94$2.99+1.8%
Q1'26$3.12$3.36+7.8%
Q4'25$2.77$2.77-0.0%
Q3'25$2.63$2.68+2.0%
Q2'25$2.94$2.96+0.6%

Revenue

EstBeatMiss
$1.5B$1.6B$1.7B$1.8B$1.9BQ2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$1.7B - -
Q2'26$1.7B$1.7B+0.2%
Q1'26$1.8B$1.9B+5.8%
Q4'25$1.7B$1.6B-1.1%
Q3'25 - $1.5B -
Q2'25 - $1.7B -

Market Data

CME Stock Snapshot

HOLD59/100
$276.01+$0.02 (0.0%)
Market cap
97.50B
P/E ratio
22.7
Day range
$267.00 – $277.49
News sentiment
54/100 · Neutral
Analyst target
$283.60 (+2.7%)
Consensus
Buy · 22 analysts
52-week range+26.4% off low · -16.1% from high
$218.31$329.16
Price $276.01 DailyIQ Est. $285.30

CME Group Inc. is consolidating: price is in the middle of its 52-week range without a decisive push either way. Sector peers are worth watching - large caps in Financial Services tend to move together on rotation.

Behaviour On Record

What CME's own history says about today's numbers

Realized volatility (21d)
22.7% 72nd pct
Below its peak
-15.7%
vs 200-day average
-1.0%
Up days (1y)
55%

CME Group Inc. is currently running 22.7% annualised volatility over the last 21 sessions. Measured against CME's own 13 years of daily returns rather than a market-wide average, that is the 72nd percentile a little above its own norm, against a typical reading of 18.9%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.

CME is trading -15.7% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -13.1%, and the deepest was -37.6% in 2020. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.

Price sits -1.0% from its 200-day moving average. Against every other day in its history, that gap ranks at the 22nd percentile a narrower gap than it typically runs. Over the past year CME closed higher on 55% of sessions, and it is currently 1 session into a rising streak.

On September specifically: over 13 years of records, CME finished the month higher 5 of 13 times, with a median return of -2.9% and an average of -1.0%. Its strongest month historically has been November at +5.7% on average, its weakest March at -3.0%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.

Overnight risk is measurable too: CME has opened more than 2% away from the prior close in 72 of 3,267 sessions (2.2% of the time), with the largest gaps running +4.9% and -7.8%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.

Across the last 3 dated reports on file, CME moved an average of 0.9% in the session after earnings, closing higher 3 of those 3 times, with a median move of +1.2% and a largest of +1.6%.

All figures computed from 3,268 daily closes between 2013-09-20 and 2026-09-18, split-adjusted, recomputed daily. Percentiles are against CME's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of CME's sector?

CME Group Inc. sits in the Financials sector, currently ranked 5th of 11 GICS sectors by relative-strength rotation score (lagging).

Sector rank
#5 of 11
Sector state
Lagging
Sector rotation score
50

Options Market

What is the options market pricing for CME?

CallsPuts

For CME Group Inc.'s nearest expiry (2026-09-25, 5 days out), open interest is put-heavy, a defensive/bearish tilt (put/call ratio of 1.63), with at-the-money implied volatility around 31.1%. The options market is pricing roughly a ±3.3% move by that expiry — a range of about $265.80–$284.20.

Put/call ratio (2026-09-25)
1.63
ATM implied volatility
31.1%
Total open interest
1,370
Expected move by 2026-09-25
±3.3% ($265.80–$284.20)

Analyst Rating Changes

Are analysts turning bullish or bearish on CME?

TD Cowen most recently reiterated its rating on CME Group Inc. to Buy on Sep 3, 2026 with a price target of $292. Over the last 90 days, coverage has run 0 upgrades against 1 downgrade, a net bearish lean.

Latest action
TD CowenBuy
90-day upgrades
0
90-day downgrades
1
Net rating momentum
-1
DateFirmActionRatingPrice target
Sep 3, 2026TD CowenReiteratedBuy$292
Aug 19, 2026Deutsche BankDowngradeBuy → Hold$286 → $270
Jul 23, 2026JP MorganMaintainedUnderweight$249 → $250
Jul 23, 2026B of A SecuritiesMaintainedUnderperform$226 → $230
Jul 23, 2026Morgan StanleyMaintainedOverweight$324 → $330
Jul 15, 2026Piper SandlerMaintainedOverweight$329 → $295
Jul 10, 2026Morgan StanleyMaintainedOverweight$353 → $324
Jul 9, 2026BarclaysMaintainedEqual-Weight$316 → $270
Jul 8, 2026TD CowenMaintainedBuy$273 → $270
Jul 6, 2026UBSMaintainedNeutral$310 → $260
Jul 2, 2026Raymond JamesReiteratedOutperform$320
Jun 22, 2026TD CowenMaintainedBuy$323 → $273

CME Competitive Positioning

CME Group Inc. (CME) is tracked alongside these names in Financial Data & Stock Exchanges on DailyIQ — ranked by market cap, with today's move alongside.